lysosomotrop
agent
caus
reduct
number
chick
kidney
ck
cell
vero
cell
infect
infecti
bronchiti
viru
ibv
strain
beaudett
determin
immunofluoresc
end
first
replic
cycl
inhibit
occur
present
first
h
infect
syncytium
format
studi
replic
ibvbeaudett
vero
cell
cellceu
fusion
occur
ph
ph
optim
ph
ibv
strain
replic
vero
cell
studi
ck
cell
grew
well
without
form
syncytia
contrast
ibvbeaudett
virtual
effect
replic
result
show
ibv
spike
glycoprotein
induc
membran
fusion
near
neutral
ph
although
ibv
strain
may
requir
mildli
acid
environ
effici
uncoat
virion
rna
member
monogener
famili
coronavirida
envelop
speci
contain
larg
spike
glycoprotein
form
bulbou
surfac
project
respons
induct
membran
fusion
small
membran
glycoprotein
expos
outer
viru
surfac
ibv
coronavirus
protein
cleav
form
aminotermin
carboxytermin
subunit
subset
coronavirus
includ
bovin
coronaviru
bcv
murin
hepat
viru
mhv
avian
ibv
contain
third
glycoprotein
haemagglutin
acetylesteras
activ
li
cavanagh
cleoprotein
rnp
compris
singl
positivesens
rna
molecul
nucleotid
surround
phosphoryl
nucleocapsid
protein
n
studi
membran
fusion
induc
coronavirus
limit
larg
mhv
bcv
host
cell
infect
either
viru
fuse
form
syncytia
cultur
medium
ph
greater
ph
less
result
indic
membran
fuse
activ
spike
glycoprotein
requir
trigger
acid
environ
contrast
orthomyxovirus
togavirus
flavivirus
moreov
result
suggest
releas
rnp
might
occur
follow
fusion
virion
envelop
cell
surfac
plasmalemma
occur
paramyxovirus
mani
mammalian
retrovirus
inde
fusion
bcv
plasmalemma
observ
fusion
coronavirus
cell
membran
also
studi
indirectli
use
lysosomotrop
agent
exampl
chloroquin
agent
rais
ph
endosom
lysosom
virus
locat
follow
endocytosi
would
expect
inhibit
releas
rnp
acid
phrequir
viru
viru
abl
fuse
neutral
ph
agreement
observ
bcv
induc
syncytia
ph
fuse
plasmalemma
littl
effect
replic
bcv
howev
chloroquin
inhibit
delay
replic
respect
investig
condit
coronavirusinduc
membran
fusion
examin
effect
acid
ph
format
syncytia
earli
stage
infect
respect
ibv
virus
cell
ibvbeaudett
adapt
growth
vero
cell
previous
describ
strain
passag
sever
time
chicken
embryo
tracheal
organ
cultur
five
time
embryo
primari
chick
kidney
ck
cell
veto
cell
atcc
ccl
flow
laboratori
irvin
scotland
ck
cell
grown
flow
eagl
minim
essenti
medium
mem
gibco
paisley
scotland
respect
supplement
foetal
calf
serum
sodium
bicarbon
penicillin
streptomycin
coz
ibvbeaudett
fitrat
plaqu
assay
vero
ck
cell
cell
wash
mem
buffer
n
hydroxyethyl
piperazinen
acid
hepe
sodium
bicarbon
infect
cell
overlaid
mem
contain
tryptos
phosphat
broth
difco
place
serum
agar
difco
sodium
bicarbon
ck
vero
cell
respect
day
second
overlay
ad
contain
neutral
red
plaqu
count
one
day
later
form
plaqu
titrat
tracheal
organ
cultur
titr
express
median
ciliostat
dose
cd
ml
order
maintain
ph
desir
valu
cell
close
flask
use
air
incub
mainten
medium
compris
mem
bovin
serum
albumin
boehringermannheim
mgml
tryptos
phosphat
difco
buffer
mm
nnbi
hydroxyethyl
aminoethan
sulfon
acid
be
sigma
differ
amount
solut
sodium
bicarbon
ad
give
desir
ph
rang
ph
valu
flask
fluctuat
within
ph
unit
h
incub
experi
fsa
laboratori
suppli
england
perform
flask
dish
besbuff
mem
ph
ad
cell
prior
infect
thereaft
present
describ
result
section
chicken
antiibv
strain
serum
ml
absorb
three
time
use
unfix
monolay
vero
cell
globulin
fraction
obtain
two
precipit
satur
ammonium
sulphat
subsequ
use
concentr
equival
dilut
origin
serum
cell
coverslip
fix
icecold
aceton
rain
cover
antiserum
h
room
temperatur
wash
replac
rabbit
antichicken
iggfluorescein
isothiocyan
bioyeda
l
h
time
cell
perman
wetmount
fluoresc
microscopi
vero
celladapt
beaudett
strain
ibv
produc
larg
distinct
syncytia
vero
cell
larger
remain
substrat
much
longer
period
syncytia
ck
cell
consequ
vero
cell
combin
ibvbeaudett
chosen
studi
ibvinduc
cell
fusion
ph
experi
medium
rang
ph
ph
interv
use
one
experi
cell
infect
multipl
infect
moi
pfucel
incub
cell
fusion
first
observ
infect
nuclei
syncytia
h
later
fusion
ph
less
ph
fig
similar
experi
ph
interv
use
rang
ph
fusion
fourfold
higher
ph
either
ph
fig
b
ascertain
whether
low
ph
irrevers
advers
affect
ibv
infect
viru
dilut
mem
ph
held
titrat
show
titr
three
sampl
within
rang
pfuml
order
determin
uncoat
ibv
genom
requir
low
ph
endosom
lysosomotrop
agent
use
rais
endosom
ph
assess
whether
would
effect
replic
ibvbeaudett
vero
ck
cell
preincub
mm
min
cell
type
inocul
dilut
determin
would
affect
attach
viru
cell
vero
cell
held
min
viru
presenc
mm
permit
attach
entri
viru
cell
cell
wash
incub
continu
absenc
h
time
cell
fix
examin
use
fluoresc
antibodi
number
group
infect
cell
follow
attach
presenc
virtual
without
total
number
cell
respect
thu
decreas
attach
viru
cell
experi
perform
determin
whether
exert
affect
ibvbeaudett
earli
postattach
late
stage
infect
cycl
one
experi
vero
cell
infect
ibvbeaudett
moi
incub
total
present
absent
shown
tabl
experi
cell
fix
infect
cell
detect
use
fluoresc
antibodi
tabl
show
presenc
infect
h
infect
effect
number
group
cell
produc
viru
protein
contrast
presenc
first
two
hour
infect
reduc
number
cell
success
infect
inoculum
approxim
intens
fluoresc
success
infect
cell
similar
irrespect
present
second
experi
confirm
result
experi
reduc
number
group
infect
cell
approxim
present
first
h
infect
experi
group
total
number
infect
cell
greater
number
cell
infect
inoculum
show
follow
remov
replic
proceed
normal
second
experi
tabl
one
group
cell
cultur
group
present
h
h
case
number
cell
product
infect
virtual
number
cell
infect
inoculum
ie
continu
presenc
inhibit
second
cycl
infect
result
show
affect
earli
stage
replic
cycl
replic
ibv
studi
ck
cell
strain
replic
veto
cell
induc
syncytium
format
ck
cell
pretreat
either
mm
mm
min
infect
either
beaudett
moi
pfuml
respect
presenc
absenc
relev
concentr
drug
h
inoculum
replac
incub
continu
present
period
indic
tabl
end
experi
medium
harvest
viru
titrat
tabl
show
wherea
mm
mm
result
decreas
respect
titr
ibvbeaudett
effect
effect
first
cycl
replic
studi
immuofluoresc
drug
present
min
infect
first
h
infect
ck
cell
grown
coverslip
fix
h
infect
result
tabl
show
drug
decreas
number
cell
product
infect
ibvbeaudett
wherea
decreas
case
result
show
littl
effect
releas
rnp
show
drug
signific
effect
stage
infect
strengthen
view
inhibit
infect
ibvbeaudett
specif
manner
probabl
genom
uncoat
two
membran
fusion
event
address
firstli
fusion
infect
cell
express
protein
surfac
neighbour
cell
form
syncytia
secondli
fusion
virion
envelop
cell
membran
examin
rais
ph
within
endosom
although
ph
condit
optim
two
process
need
observ
syncytium
format
vero
cell
lack
inhibitori
effect
replic
ck
cell
lead
conclus
name
protein
ibv
fusogen
activ
around
neutral
ph
rais
ph
endosom
almost
ph
find
partial
inhibit
replic
ibv
keep
find
beaudetteinduc
syncytium
format
occur
less
extens
ph
fig
increas
endosom
ph
may
result
reduct
rate
membran
fusion
virion
transfer
destroy
lysosom
failur
inhibit
replic
ibv
show
fusion
viru
cell
membran
lead
genom
uncoat
occur
ph
thu
drop
ph
occur
within
endosom
requir
membran
fusion
viru
allow
possibilti
uncoat
could
occur
viru
plasmalemma
fusion
bcv
virion
mebu
strain
plasmalemma
endosom
membran
cell
observ
electronmicroscopi
addit
reduc
output
bcv
small
degre
lead
conclus
bcv
genom
uncoat
requir
acid
ph
occur
cell
surfac
electron
microscop
analysi
entri
ibvbeaudett
chicken
chorioaltanto
membran
cell
ck
cell
show
entri
phagocytosi
micropinocytosi
evid
fusion
ibvbeaudett
plasmalemma
although
fusion
within
vesicl
observ
either
whether
fusion
occur
cell
surfac
within
vesicl
even
viru
acid
environ
requir
depend
rate
fusion
rel
speed
endocytosi
evid
support
view
fusion
activ
protein
coronavirus
requir
low
ph
provid
observ
bcvinduc
syncytium
format
occur
ph
ph
prevent
syncytium
induct
viru
replic
wherea
ph
cellcel
fusion
extens
vaccinia
virusexpress
protein
felin
infecti
periton
viru
fipv
mhvjhm
also
caus
cellcel
fusion
standard
bicarbonatebuff
media
howev
vero
cell
syncytia
induc
ibvbeaudett
clearli
form
optim
ph
locat
amino
acid
differ
protein
ibv
strain
beaudett
respons
differ
ph
requir
membran
fusion
activ
might
investig
produc
variou
hybrid
gene
determin
ph
requir
subsequ
express
protein
gallagh
et
al
recent
use
approach
studi
variant
like
two
ibv
strain
describ
herein
differ
ph
requir
membran
fusion
suscept
